Cynosure Group LLC Cuts Stock Position in Molina Healthcare, Inc. (NYSE:MOH)

Cynosure Group LLC trimmed its holdings in shares of Molina Healthcare, Inc. (NYSE:MOH) by 7.5% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 970 shares of the company’s stock after selling 79 shares during the period. Cynosure Group LLC’s holdings in Molina Healthcare were worth $282,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Versant Capital Management Inc increased its stake in shares of Molina Healthcare by 83.1% during the fourth quarter. Versant Capital Management Inc now owns 163 shares of the company’s stock worth $47,000 after purchasing an additional 74 shares in the last quarter. Wingate Wealth Advisors Inc. acquired a new stake in Molina Healthcare in the 4th quarter worth about $52,000. EverSource Wealth Advisors LLC increased its stake in Molina Healthcare by 81.5% during the 4th quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company’s stock worth $57,000 after buying an additional 88 shares in the last quarter. Whittier Trust Co. of Nevada Inc. raised its holdings in shares of Molina Healthcare by 337.0% during the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company’s stock valued at $58,000 after acquiring an additional 155 shares during the last quarter. Finally, Harvest Fund Management Co. Ltd lifted its position in shares of Molina Healthcare by 895.0% in the fourth quarter. Harvest Fund Management Co. Ltd now owns 199 shares of the company’s stock valued at $58,000 after acquiring an additional 179 shares in the last quarter. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total value of $301,330.00. Following the sale, the director now owns 17,375 shares of the company’s stock, valued at $5,235,608.75. The trade was a 5.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.10% of the stock is currently owned by corporate insiders.

Molina Healthcare Trading Up 7.6 %

MOH opened at $353.48 on Friday. The stock has a market capitalization of $19.34 billion, a PE ratio of 17.30, a P/E/G ratio of 1.06 and a beta of 0.56. Molina Healthcare, Inc. has a one year low of $262.32 and a one year high of $383.58. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. The business’s 50 day moving average price is $305.90 and its 200 day moving average price is $308.82.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 EPS for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. As a group, equities research analysts expect that Molina Healthcare, Inc. will post 24.4 EPS for the current year.

Analyst Ratings Changes

Several analysts recently commented on the company. Wells Fargo & Company upgraded Molina Healthcare from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $295.00 to $372.00 in a research report on Wednesday, March 5th. StockNews.com lowered shares of Molina Healthcare from a “buy” rating to a “hold” rating in a report on Thursday. Truist Financial decreased their price target on shares of Molina Healthcare from $370.00 to $340.00 and set a “buy” rating on the stock in a research note on Wednesday, February 19th. UBS Group dropped their price objective on shares of Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating for the company in a research note on Friday, February 7th. Finally, Barclays decreased their target price on shares of Molina Healthcare from $372.00 to $339.00 and set an “equal weight” rating on the stock in a research note on Friday, February 7th. Seven investment analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $348.75.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.